发明名称 NOVEL PYRIDINE DERIVATIVE AND PYRIMIDINE DERIVATIVE (2)
摘要 <p>A compound of the following general formula or its salt or a hydrate thereof exhibits excellent hepatocyte growth factor receptor (HGFR) inhibiting activity and provides a compound having antitumor activity, vascularization inhibiting activity or cancer metastasis inhibiting activity or its salt or a hydrate thereof. (wherein R&lt;1&gt; represents a C1-C6 alkyl, etc.; each of R&lt;2&gt; and R&lt;3&gt; represents a hydrogen atom; R&lt;4&gt;, R&lt;5&gt;, R&lt;6&gt; and R&lt;7&gt; may be identical with or different from each other and each represent a hydrogen atom, a halogen atom, a C1-C6 alkyl, etc.; R&lt;8&gt; represents a hydrogen atom, etc.; R&lt;9b&gt; represents a 3 to 10-membered nonaromatic heterocyclic group, etc.; V&lt;1&gt; represents an oxygen atom, etc.; V&lt;2&gt; represents an oxygen atom or a sulfur atom; W represents a group of the formula -CH2-, etc.; X represents a group of the formula -CH=, a nitrogen atom, etc.; and Y represents an oxygen atom, etc.).</p>
申请公布号 WO2005082855(A1) 申请公布日期 2005.09.09
申请号 WO2005JP03704 申请日期 2005.02.25
申请人 EISAI CO., LTD.;MATSUSHIMA, TOMOHIRO;TAKAHASHI, KEIKO;FUNASAKA, SETSUO;OBAISHI, HIROSHI 发明人 MATSUSHIMA, TOMOHIRO;TAKAHASHI, KEIKO;FUNASAKA, SETSUO;OBAISHI, HIROSHI
分类号 A61K31/44;A61K31/4409;A61K31/4427;A61K31/4439;A61K31/444;A61K31/4545;A61K31/496;A61K31/505;A61K31/506;A61K31/5377;A61K31/551;A61P1/18;A61P9/00;A61P11/00;A61P13/08;A61P13/12;A61P15/00;A61P25/00;A61P35/00;A61P35/04;A61P43/00;C07D213/73;C07D213/75;C07D239/46;C07D239/47;C07D239/48;C07D401/12;C07D401/14;C07D403/12;C07D407/12;C07D409/12;C07D413/12;C07D487/08;(IPC1-7):C07D213/75;A61K31/537;A61K31/442 主分类号 A61K31/44
代理机构 代理人
主权项
地址